HER 2 POSITIVE BREAST CANCER
Clinical trials for HER 2 POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER 2 POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HER 2 POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for Tough-to-Treat breast cancer
Disease control OngoingThis study tests whether adding the drug palbociclib to standard anti-HER2 and hormone therapy helps people with a specific type of advanced breast cancer (HR+/HER2+) live longer without their cancer getting worse. About 518 participants are being followed to compare the combinat…
Matched conditions: HER 2 POSITIVE BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New drug combo shows promise in shrinking aggressive breast tumors before surgery
Disease control OngoingThis study tests whether giving two targeted drugs (T-DM1 and pertuzumab) before surgery can eliminate all signs of cancer in women with early-stage HER2-positive breast cancer. About 164 participants with stage II or III disease will receive the combination, and doctors will che…
Matched conditions: HER 2 POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC